PRICE T ROWE ASSOCIATES INC /MD/
Position in APLS — Apellis Pharmaceuticals, Inc.
CIK 80255
BALTIMORE, MD
Position in APLS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
106,908
+12.5% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APLS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in APLS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 106,908 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | — | 95,035 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | — | 97,940 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | — | 92,151 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | — | 90,700 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | — | 358,578 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | — | 378,456 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | — | 1,276,426 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | — | 2,459,246 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | — | 2,460,339 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | — | 1,783,241 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | — | 7,072,226 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | — | 4,590,040 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | — | 2,749,542 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | — | 3,350,963 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | — | 8,679,813 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | — | 7,884,839 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | — | 5,298,491 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | — | 4,807,077 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | — | 5,170,494 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | — | 3,642,149 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | — | 3,045,329 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | — | 2,978,400 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | — | 3,027,835 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | — | 1,250,870 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||